Boston Scientic lands 3 FDA approvals

Natick medical-device maker Boston Scientific Corp. said today that it has received Food & Drug Administration approval for three products in its cardiac rhythm management business.

The products include the Confient implantable cardioverter defibrillator, the Livian cardiac resynchronization therapy defibrillator, and an upgraded Latitude patient management system, the company said.

"Our cardiac rhythm management team is refocused on delivering therapy systems that meet physicians' needs for safety, reliability, and better patient outcomes," company president and chief executive Jim Tobin said in a statement. "These and other recent approvals are tangible examples of the team's revitalized commitment to quality and innovation."
(By Chris Reidy, Globe staff)